How can hepatitis B patients prevent liver cancer? Hepatitis B patients should pay attention to the following points in preventing liver cancer

Hepatitis B patients with positive hepatitis B virus are also one of the groups infected with hepatitis B virus. The symptoms of hepatitis B patients are not obvious and their liver function is usually normal. However, if they do not pay attention to daily conditioning, liver disease can easily worsen unknowingly. Hepatitis B patients with positive hepatitis B virus are more likely to develop into liver cancer. Patients with hepatitis B virus with normal liver function should especially prevent further malignant transformation of hepatitis B virus.

"Xiao Sanyang" is more likely to develop into liver cancer

Among a large number of chronic hepatitis B virus carriers or patients with chronic hepatitis B and liver cirrhosis, the vast majority are "small three positive". Moreover, the conversion rate of "small three positive" to liver cancer is more than 12 times higher than that of "big three positive". Experts pointed out that for a long time, people generally regarded the conversion of "big three positive" to "small three positive" as an effective indicator of antiviral treatment, which is not rigorous. The goal of chronic hepatitis B treatment is to prevent it from evolving into cirrhosis and primary liver cancer. Elevated transaminase is the best time for antiviral treatment of hepatitis B.

A large number of clinical tests have found that it is not difficult to convert "big three positive" to "small three positive". 46.2% of patients have automatically turned negative without treatment. However, a large number of chronic hepatitis B virus carriers or chronic hepatitis B and liver cirrhosis patients in the population are mostly in the "small three positive" mode. In addition, there are figures showing that 88% of liver cirrhosis in the population is related to hepatitis B virus infection, and the main modes are "small three positive" (40.79%) and "small two positive" (28.71%), which together account for 69.5%, while "big three positive" is only 30.5%.

A study of 178 cases of primary liver cancer and hepatitis B virus infection found that 83.95% of patients were positive for hepatitis B surface antigen, of which 53.69% were "small three positive" and only 4.32% were "big three positive". "That is to say, the probability of 'small three positive' turning into liver cancer is more than 12 times higher than 'big three positive'."

Blind pursuit of "negative conversion" leads to excessive medication

Experts point out that for a long time, many patients or doctors, due to lack of comprehensive understanding of the characteristics of hepatitis B, often instill in patients the idea that only "positive to negative" is effective and the condition can be stable, otherwise it may develop into cirrhosis or liver cancer. Some informal medical institutions also use this to scare patients and keep asking them to take medicine. Experts point out that this one-sided pursuit of positive to negative not only leads to poor treatment results, but also causes patients to overuse medicine and causes them heavy psychological burdens and financial pressures.

The key to controlling chronic hepatitis B is to prevent liver cancer

Experts pointed out that they found in clinical practice that some patients have the misunderstanding that "antiviral treatment is too expensive, and only taking liver protection and enzyme reduction drugs is enough" when treating hepatitis B. Experts said that although liver protection and enzyme reduction drugs have clear efficacy, are widely used, are relatively cheap, and generally have immediate effects, these drugs cannot inhibit the hepatitis B virus in the patient's body, which can be said to be a temporary solution but not a permanent cure.

Experts believe that the goal of treating chronic hepatitis B is to prevent it from evolving into cirrhosis and primary liver cancer, so antiviral treatment cannot be ignored. "And elevated transaminase is the best time for antiviral treatment of hepatitis B. Because the immune cells in the human body are in an activated state at this time, treatment can achieve twice the result with half the effort."

Therefore, treatment of Hepatitis B virus (HBV) should not be neglected. Regular check-ups are required to detect changes in the disease in a timely manner to avoid inducing cancer. In addition, experts said that for patients with Hepatitis B virus (HBV) virus with normal liver function, the following aspects should be noted:

(1) Patients with Hepatitis B virus (HBV) and normal liver function should go to a regular hospital for regular liver function and hepatitis B five-item tests, and always pay attention to changes in their condition to prevent it from worsening.

(2) Patients with Hepatitis B virus (HBV) and positive test results who have normal liver function should receive anti-fibrosis treatment in a timely manner. Surveys show that patients with Hepatitis B virus (HBV) and positive test results have a very high degree of liver fibrosis, and some even develop cirrhosis or liver cancer. Therefore, patients with Hepatitis B virus (HBV) and positive test results who have normal liver function should receive anti-fibrosis treatment before their condition worsens.

(3) Hepatitis B patients with normal liver function should develop regular living habits and take medication under the guidance of a doctor. They should pay attention to nourishing and protecting the liver through diet therapy, exercise more, and maintain a positive and optimistic attitude to treat hepatitis B.